HERCULES CAPITAL, INC.

(HTGC)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
05/10/2022 05/11/2022 05/12/2022 05/13/2022 05/16/2022 Date
16.1(c) 15.75(c) 15.03(c) 15.2(c) 15.11 Last
2 964 596 2 772 578 3 401 047 2 171 471 1 955 003 Volume
-0.80% -2.17% -4.57% +1.13% +2.65% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 293 M - -
Net income 2022 125 M - -
Net Debt 2022 - - -
P/E ratio 2022 14,9x
Yield 2022 12,7%
Sales 2023 332 M - -
Net income 2023 187 M - -
Net Debt 2023 - - -
P/E ratio 2023 10,1x
Yield 2023 8,88%
Capitalization 1 852 M 1 852 M -
Capi. / Sales 2022 6,33x
Capi. / Sales 2023 5,59x
Nbr of Employees -
Free-Float 98,6%
More Financials
Company
Hercules Capital, Inc. is a specialty finance company. It is focused on providing senior secured loans to venture capital-backed and institutional-backed companies in a variety of technology, life sciences and sustainable and renewable technology industries. The Company is an internally managed, non-diversified, closed-end investment company. Its investment objective is to maximize its portfolio total return by... 
More about the company
Ratings of Hercules Capital, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about HERCULES CAPITAL, INC.
05/16HERCULES CAPITAL, INC. : Ex-dividend day for
FA
05/13INSIDER BUY : Hercules Capital
MT
05/10Hercules Capital Receives BBB- Investment Grade Credit and Corporate Rating from Fitch ..
BU
05/10Fitch Assigns 'BBB-' Rating to Hercules Capital; Outlook Stable
AQ
05/09HERCULES CAPITAL, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
05/09Hercules Capital Announces Date of 2022 Annual Meeting of Stockholders
BU
05/05TRANSCRIPT : Hercules Capital, Inc., Q1 2022 Earnings Call, May 05, 2022
CI
05/05HERCULES CAPITAL, INC. : Results of Operations and Financial Condition, Other Events, Fina..
AQ
05/05HERCULES CAPITAL, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
AQ
05/05Hercules Capital Reports First Quarter 2022 Financial Results
BU
05/05Hercules Capital, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2..
CI
05/04Phathom Pharmaceuticals Secures Financing of Up to $260 Million
MT
05/03Hercules Capital Announces Supplemental Cash Distribution of $0.15 per Share for the Fi..
BU
05/03Hercules Capital, Inc. Announces Supplemental Cash Distribution for the First Quarter o..
CI
05/03Hercules Capital, Inc. Announces Cash Distribution for the First Quarter of 2022, Payab..
CI
More news
News in other languages on HERCULES CAPITAL, INC.
05/13ACHATS D'INITIÉS : Hercules Capital
05/05Hercules Capital, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars ..
05/04Phathom Pharmaceuticals obtient un financement allant jusqu'à 260 millions de dollars
05/03Hercules Capital, Inc. annonce une distribution supplémentaire en espèces pour le premi..
05/03Hercules Capital, Inc. annonce une distribution en espèces pour le premier trimestre de..
More news
Analyst Recommendations on HERCULES CAPITAL, INC.
More recommendations
Chart HERCULES CAPITAL, INC.
Duration : Period :
Hercules Capital, Inc. Technical Analysis Chart | HTGC | US4270965084 | MarketScreener
Technical analysis trends HERCULES CAPITAL, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Last Close Price 15,11 $
Average target price 18,44 $
Spread / Average Target 22,1%
EPS Revisions
Managers and Directors
Scott Bluestein President, Chief Executive Officer & Director
Seth H. Meyer Chief Financial & Accounting Officer
Robert P. Badavas Chairman
Steve Kuo Senior Managing Director & Group Head-Technology
Christian Follmann Chief Operating Officer
Sector and Competitors